These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1169 related articles for article (PubMed ID: 12754523)

  • 1. Expression profiling reveals off-target gene regulation by RNAi.
    Jackson AL; Bartz SR; Schelter J; Kobayashi SV; Burchard J; Mao M; Li B; Cavet G; Linsley PS
    Nat Biotechnol; 2003 Jun; 21(6):635-7. PubMed ID: 12754523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene expression silencing with 'specific' small interfering RNA goes beyond specificity - a study of key parameters to take into account in the onset of small interfering RNA off-target effects.
    Vankoningsloo S; de Longueville F; Evrard S; Rahier P; Houbion A; Fattaccioli A; Gastellier M; Remacle J; Raes M; Renard P; Arnould T
    FEBS J; 2008 Jun; 275(11):2738-53. PubMed ID: 18422646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific HIV-1 env gene silencing by small interfering RNAs in human peripheral blood mononuclear cells.
    Park WS; Hayafune M; Miyano-Kurosaki N; Takaku H
    Gene Ther; 2003 Nov; 10(24):2046-50. PubMed ID: 14566364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of test systems for RNAinterference.
    Malik I; Garrido M; Bähr M; Kügler S; Michel U
    Biochem Biophys Res Commun; 2006 Mar; 341(1):245-53. PubMed ID: 16423323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of target site accessibility on the design of effective siRNAs.
    Tafer H; Ameres SL; Obernosterer G; Gebeshuber CA; Schroeder R; Martinez J; Hofacker IL
    Nat Biotechnol; 2008 May; 26(5):578-83. PubMed ID: 18438400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying siRNA-induced off-targets by microarray analysis.
    Anderson E; Boese Q; Khvorova A; Karpilow J
    Methods Mol Biol; 2008; 442():45-63. PubMed ID: 18369777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Choice of the adequate detection time for the accurate evaluation of the efficiency of siRNA-induced gene silencing.
    Choi I; Cho BR; Kim D; Miyagawa S; Kubo T; Kim JY; Park CG; Hwang WS; Lee JS; Ahn C
    J Biotechnol; 2005 Nov; 120(3):251-61. PubMed ID: 16095743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNA interference detected 20 years ago?
    Schmidt FR
    Nat Biotechnol; 2004 Mar; 22(3):267-8. PubMed ID: 14990942
    [No Abstract]   [Full Text] [Related]  

  • 9. Long-term RNA interference from optimized siRNA expression constructs in adult mice.
    Wooddell CI; Van Hout CV; Reppen T; Lewis DL; Herweijer H
    Biochem Biophys Res Commun; 2005 Aug; 334(1):117-27. PubMed ID: 15993838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of assembly of siRNA elements into RNA-induced silencing complex by fork-siRNA duplex carrying nucleotide mismatches at the 3'- or 5'-end of the sense-stranded siRNA element.
    Ohnishi Y; Tokunaga K; Hohjoh H
    Biochem Biophys Res Commun; 2005 Apr; 329(2):516-21. PubMed ID: 15737617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene silencing through RNA interference (RNAi) in vivo: strategies based on the direct application of siRNAs.
    Aigner A
    J Biotechnol; 2006 Jun; 124(1):12-25. PubMed ID: 16413079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNA interference (RNAi) in hematology.
    Scherr M; Steinmann D; Eder M
    Ann Hematol; 2004 Jan; 83(1):1-8. PubMed ID: 14574462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3' UTR seed matches, but not overall identity, are associated with RNAi off-targets.
    Birmingham A; Anderson EM; Reynolds A; Ilsley-Tyree D; Leake D; Fedorov Y; Baskerville S; Maksimova E; Robinson K; Karpilow J; Marshall WS; Khvorova A
    Nat Methods; 2006 Mar; 3(3):199-204. PubMed ID: 16489337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxicogenomics of non-viral drug delivery systems for RNAi: potential impact on siRNA-mediated gene silencing activity and specificity.
    Akhtar S; Benter I
    Adv Drug Deliv Rev; 2007 Mar; 59(2-3):164-82. PubMed ID: 17481774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomewide view of gene silencing by small interfering RNAs.
    Chi JT; Chang HY; Wang NN; Chang DS; Dunphy N; Brown PO
    Proc Natl Acad Sci U S A; 2003 May; 100(11):6343-6. PubMed ID: 12730368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Competition potency of siRNA is specified by the 5'-half sequence of the guide strand.
    Yoo JW; Kim S; Lee DK
    Biochem Biophys Res Commun; 2008 Feb; 367(1):78-83. PubMed ID: 18164261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNAi microarray analysis in cultured mammalian cells.
    Mousses S; Caplen NJ; Cornelison R; Weaver D; Basik M; Hautaniemi S; Elkahloun AG; Lotufo RA; Choudary A; Dougherty ER; Suh E; Kallioniemi O
    Genome Res; 2003 Oct; 13(10):2341-7. PubMed ID: 14525932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening of siRNA target sequences by using fragmentized DNA.
    Kasim V; Taira K; Miyagishi M
    J Gene Med; 2006 Jun; 8(6):782-91. PubMed ID: 16532512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthetic dsRNA Dicer substrates enhance RNAi potency and efficacy.
    Kim DH; Behlke MA; Rose SD; Chang MS; Choi S; Rossi JJ
    Nat Biotechnol; 2005 Feb; 23(2):222-6. PubMed ID: 15619617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonviral vector-mediated RNA interference: its gene silencing characteristics and important factors to achieve RNAi-based gene therapy.
    Takahashi Y; Nishikawa M; Takakura Y
    Adv Drug Deliv Rev; 2009 Jul; 61(9):760-6. PubMed ID: 19386274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 59.